Additionally, modulation of PPARGC1A or IRS1 may directly improve insulin sensitivity. Future research priorities should include longitudinal studies to establish causality and the exploration of chromatin-modifying therapies for PCOS-specific epigenetic markers. This evidence concerns the gene IRS1 and polycystic ovary syndrome.